48
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy

, , &
Pages 734-742 | Received 23 Jan 1984, Published online: 11 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

C. Castelo-Branco & J. Dávila Guardia. (2015) Use of ossein–hydroxyapatite complex in the prevention of bone loss: a review. Climacteric 18:1, pages 29-37.
Read now

Articles from other publishers (16)

Shrinath Bhat, U. T. Uthappa, Tariq Altalhi, Ho-Young Jung & Mahaveer D. Kurkuri. (2021) Functionalized Porous Hydroxyapatite Scaffolds for Tissue Engineering Applications: A Focused Review. ACS Biomaterials Science & Engineering 8:10, pages 4039-4076.
Crossref
Hamad Khalid & Aqif Anwar Chaudhry. 2020. Handbook of Ionic Substituted Hydroxyapatites. Handbook of Ionic Substituted Hydroxyapatites 85 115 .
Kittima Bootdee, Brian P. Grady & Manit Nithitanakul. (2017) Magnetite/poly(D,L-lactide-co-glycolide) and hydroxyapatite/poly(D,L-lactide-co-glycolide) prepared by w/o/w emulsion technique for drug carrier: physical characteristic of composite nanoparticles. Colloid and Polymer Science 295:10, pages 2031-2040.
Crossref
Camil Castelo-Branco, Jhery Dávila, Lina Alvarez & Juan Balasch. (2015) Comparison of the effects of calcium carbonate and ossein–hydroxyapatite complex on back and knee pain and quality of life in osteopenic perimenopausal women. Maturitas 81:1, pages 76-82.
Crossref
John C. Gray & Ola Grimsby. 2012. Physical Therapy of the Shoulder. Physical Therapy of the Shoulder 87 130 .
Nhiem Tran & Thomas J. Webster. (2011) Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomaterialia 7:3, pages 1298-1306.
Crossref
Robert P Heaney, Robert R Recker, Patrice Watson & Joan M Lappe. (2010) Phosphate and carbonate salts of calcium support robust bone building in osteoporosis. The American Journal of Clinical Nutrition 92:1, pages 101-105.
Crossref
Camil Castelo-Branco, Manel Ciria-Recasens, María J. Cancelo-Hidalgo, Santiago Palacios, Javier Haya-Palazuelos, Jordi Carbonell-Abelló, Josep Blanch-Rubió, María J. Martínez-Zapata, José Manasanch & Lluís Pérez-Edo. (2009) Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss. Menopause 16:5, pages 984-991.
Crossref
Irene Pelayo, Javier Haya, Juan J. De la Cruz, Carlos Seco, Juan I. Bugella, Jose L. Diaz, Jose M. Bajo & Manuel Repolles. (2008) Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women. Menopause 15:6, pages 1132-1138.
Crossref
Antonio Fern??ndez-Pareja, Elena Hern??ndez-Blanco, Jos?? Manuel P??rez-Maceda, Vicente Jos?? Riera Rubio, Javier Haya Palazuelos & Jos?? Manasanch Dalmau. (2007) Prevention of Osteoporosis. Clinical Drug Investigation 27:4, pages 227-232.
Crossref
F I Tovey, M Hobsley, M L Hall & P J Ell. (1991) Postgastrectomy osteoporosis. British Journal of Surgery 78:11, pages 1335-1337.
Crossref
David Seaman. (2004) Health Care For Our Bones: A Practical Nutritional Approach to Preventing Osteoporosis. Journal of Manipulative and Physiological Therapeutics 27:9, pages 591-595.
Crossref
John C. Gray & Ola Grimsby. 2004. Physical Therapy of the Shoulder. Physical Therapy of the Shoulder 133 185 .
P. Rüegsegger, A. Keller & M. A. Dambacher. (1995) Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporosis International 5:1, pages 30-34.
Crossref
C. Reinicke. 1986. 199 216 .
A. Stellon, A. Davies, A. Webb & R. Williams. (1985) Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis.. Postgraduate Medical Journal 61:719, pages 791-796.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.